What recent paediatric guidelines mean for drug developers
Drug Discovery World
JULY 25, 2023
As such, guidance from the FDA and EMA on paediatric drug development and long-term safety is greatly appreciated, particularly given the unique challenges presented by this vulnerable population. General clinical pharmacology This FDA draft guidance was previously issued in 2014 but was re-issued for comments again in 2022.
Let's personalize your content